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Abstract 
Coxsackievirus A16 (CV-A16) is the leading cause of hand-foot-mouth disease (HFMD), which usually 
presents as mild and self-limiting symptoms in young children. Rarely, CV-A16 has been reported 
to cause severe and fatal neurological complications but little is known about these complications. 
In the present study, 1-day and 7-day old mouse models of CV-A16 were developed using a clinical 
strain via subcutaneous inoculation. All infected mice exhibited clinical signs of infection, including 
reduced mobility, limb weakness and paralysis between 3 to 6 days post-infection. Pathologically, 
the main organs involved were the central nervous system (CNS), skeletal muscles and brown fat. In 
the CNS, viral antigens as demonstrated by immunohistochemistry, were localized mainly to neurons 
in the brain stem and spinal cord, suggesting that CV-A16 is neurotropic although inflammation is 
very mild.  The skeletal muscles showed necrosis and myositis due to viral infection as evidenced by 
the dense viral antigens. Focal viral antigens were also detected in the brown fat. These preliminary 
pathological findings indicate that our mouse models can be further developed to be useful models 
for pathogenesis studies, and vaccine and anti-viral drug evaluation.
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INTRODUCTION
Coxsackievirus A16 (CV-A16) is a non-enveloped, 
single-stranded, positive-sense RNA virus from 
the family of Picornaviridae. First isolated in 
South Africa in 19511, it infects humans via 
faecal-oral or oral-oral routes.2,3 Together with 
enterovirus 71 (EV-A71), CV-A16 is one of the 
most important pathogens that causes hand-foot-
mouth disease (HFMD).  The usual mild clinical 
manifestations of HFMD are fever, vesicles/
rashes on the palmar and plantar skin, and ulcers 
on the buccal mucosa and tongue.4 Very rarely, 
severe and fatal neurological complications e.g. 
rhombencephalitis and myocarditis have been 
associated with CV-A16.5-8
 In contrast to EV-A71 encephalomyelitis in 
which human autopsies have been studied9-11, 
human pathology and neuropathogenesis of CV-
A16 infection is unknown. Therefore, it is essential 
to develop animal models to better understand 
the infectious disease pathology of the virus, 
particularly its neurotropism. Previously, a few 
animal models of CV-A16 have been developed 
as tools for vaccine and anti-viral drug evaluation. 
In these models, the pathological findings 
suggest that the virus may have a predilection 
for the brainstem and cerebellum.12,13 However, 
we believe, this has not been convincingly 
demonstrated. In the present study, a mouse model 
was established to investigate the neurotropism 
and viral tropism for non-central nervous system 
(CNS) tissues of a clinically-isolated CV-A16 
strain. The findings in this model extend our 
knowledge of CV-A16pathogenesis. Moreover, 
this mouse model could also be potentially useful 
for testing new anti-viral drugs and vaccines.
METHODS
Virus stock and cell culture
A clinical isolate of CV-A16 (CV-A16-N132), 
obtained from a HFMD patient was used for 
our experiments. The virus was propagated in 
Vero cells maintained in Dulbecco’s Modified 
Eagle Medium (DMEM, Sigma-Aldrich, USA) 
maintenance medium supplemented with 2% 
fetal bovine serum (FBS, JR Scientific, USA). 
The culture was kept until the cells showed >90% 
cytopathic effect. After 3 freeze-thaw cycles and 
centrifugation at 4000rpm for 10 min at 4˚C, 
the supernatant was filtered through a 0.22µm 
pore-size filter (Minisart; Sartorius, Germany), 
aliquoted and stored at -80˚C before use. The 
viral titers were determined by measuring 50% 
